Clinical Trial Key Documents

Level 2

  • 1

    Module 1: Investigator Drug Brochure

    • slide 1

    • 2

    • slide 3

    • slide 4

    • slide 5

    • slide 6

    • slide 7

    • Knowledge Checkpoints 01

    • slide 8

    • slide 9

    • slide 10

    • slide 11

    • Knowledge Checkpoints 02
  • 2

    Module 2: Protocol

    • slide 1

    • slide 2

    • slide 3

    • slide 4

    • slide 5

    • Knowledge Checkpoints 01

    • slide 6

    • slide 7

    • slide 8

    • slide 9_01

    • slide 10

    • slide 11

    • slide 12

    • slide 13

    • Knowledge Checkpoints 02

    • slide 14

    • slide 15

    • slide 16

    • slide 17

    • slide 18

    • slide 19

    • slide 20

    • slide 21

    • slide 22

    • Knowledge Checkpoints 03
  • 3

    Module 3: CRF

    • slide 1

    • slide 2

    • slide 3

    • slide 4

    • slide 5

    • slide 6

    • slide 7

    • slide 8

    • slide 9

    • slide 10

    • Knowledge Checkpoints 01

    • slide 11

    • slide 12

    • slide 13

    • slide 14

    • Knowledge Checkpoints 02
  • 4

    Module 4: PI and PIC

    • Module 4: PI and PIC

  • 5

    Module 5: Site Agreements

    • slide 2

    • slide 3

    • slide 4

    • slide 5

    • Knowledge Checkpoint 01

    • slide 6

    • slide 7

    • slide 8

    • slide 9

    • slide 10

    • slide 11

    • slide 12

    • Knowledge Checkpoints 02

    • slide 13

    • slide 14_1

    • Knowledge Checkpoints 03

    • slide 15

Instructor

Chief Operating Officer

Dr Tina Barton

Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.